Altria Group (NYSE:MO) shares climb, pressuring yield spread as FDA rule draws talk on volumes
Altria surged 6.8% last week to $73.79, just 1% below its 52-week high, adding $7.8 billion in equity value even as the S&P 500 fell 2.05%; investors face a fresh regulatory risk/reward calculus after the FDA proposed new rules for foreign tobacco makers, while heavy trading volume was driven in part by the Russell index reset.